PALM BEACH, Florida, June 4, 2020/ PRNewswire/– According to an article by the National Marijuana Market Association, Nanoemulsions will have an impact in the medical, beverage and instilled markets in the coming months and years. Customers and manufacturers of products that have been instilled with THC or CBD are most likely really knowledgeable about two key problems that pester the product class: sluggish onset time and unequal dosing of the active ingredient. In a bid to provide a solution, lots of groups are marketing “water-soluble technology,” or “nanotechnology.” The vast majority of the groups claiming water-soluble (more appropriately described as “water-compatible”) technology are providing a nanoemulsion. Nanoemulsion innovation is a very promising and accessible option. It has the capability to allow for both (1) fast start and (2) consistent circulation of the active component in infused items such as drinks, gummies, and water-based topicals. When made small enough, the particles distribute evenly in water and will not separate out into bigger globs of oil. Other added advantages are increased absorption of the active component. Active companies in the markets today include: Pressure BioSciences, Inc.(OTCQB: PBIO), Canopy Development Corporation ( NYSE: CGC) (TSX: WEED), HEXO Corp. ( NYSE: HEXO) (TSX: HEXO), Cronos Group Inc. ( NASDAQ: CRON) (TSX: CRON), ycbdMD, Inc. ( NYSE: YCBD).

Another study by Coherent Marketing Insights added: “There are several benefits of nanoemulsion over traditional emulsion. One such benefit is the extreme micro-droplet size of nanoemulsion with high surface location, which makes them extremely efficient as a transport system.

Pressure BioSciences, Inc (OTCQB: PBIO) BREAKING NEWS: Pressure BioSciences Announces First Production Build Totally Offered Out for Revolutionary UST System for Processing Hemp-Derived Cannabinoid Oil into Stable, Water-Soluble Nanoemulsions – Pressure BioSciences today announced the invoice of an order for the 12 th and final system set up to be integrated in the Business’s preliminary manufacturing run of its innovative BaroShear ™ K45 processing system. Based on the Company’s exclusive Ultra Shear Innovation ™ (UST ™) platform, the BaroShear K45 is a special and powerful nanoemulsification system developed to fix one of the most vital issues facing the global hemp-derived cannabinoid market today: how to make hemp-derived cannabinoid oil efficiently soluble in water, to enhance absorption and bioavailability when taken in or applied. The cannabidiol market is forecasted to exceed $20 B by 2024 ( Forbes, May 2019).

Hemp-derived cannabinoids are extracted from the hemp plant in an oil.

The Company formerly revealed plans for its first production run of twelve (12) BaroShear K45 processing systems with approximated completion times throughout the 4th quarter of2020 Due to inefficiencies brought on by the COVID-19 pandemic, the Company now believes that all 12 systems will be finished in time for delivery and setup to take place during the first quarter of 2021.

Mr. Kenneth F. Micciche, Director of PBI’s UST Program, said: “The order for the last available BaroShear K45 system from our preliminary production run was gotten from an amazing young company out of Massachusetts called Canopy CBD Farms, LLC. They use just the highest quality hemp biomass available and the latest processing technologies to meet or surpass market requirements.

Mr. John Westlake, Founder and President of Canopy CBD Farms, LLC., commented: “Scientific information highly supports the critical understanding that hemp-derived cannabinoid oil requires to be processed into an effectively water-soluble, long-term steady nanoemulsion to attain the highest quality hemp-derived cannabinoid products possible. After an exhaustive evaluation of offered technologies, a comprehensive evaluation of UST-processed hemp-derived cannabinoid materials, and a comprehensive and incorporating site see, we concluded the BaroShear K45 was unequaled in deep space of nanoemulsion processing platforms. As we are committed to utilizing only the best devices in our own manufacturing, and convinced that the BaroShear K45 will give us lots of competitive advantages in the marketplace, it was a simple decision for us to put this order for the 12 th and last BaroShear K45 system in PBI’s initial production run.”

Mr. Richard T. Schumacher, President and CEO of PBI, commented: “We are very gratified and ecstatic that the initial manufacturing run of our BaroShear K45 processing systems has actually sold out. We are also pleased that an outstanding, up-and-coming business like Canopy CBD Farms was able to take part in and position an order for the last available unit in our very first manufacturing run. We are positive that the BaroShear K45 will differentiate them in the marketplace with a considerable benefit over their competitors.” Read this and more news for Pressure BioSciences at:

Other current advancements in the markets include:

Canopy Growth Corporation ( NYSE: CGC) (TSX: WEED.TO) has recently supplied updates on the Business’s 2.0 development items that have actually released into the Canadian recreational market in early 2020, and extra approaching item releases.

The first wave of the Company’s ready-to-drink cannabis-infused beverages — Tweed Houndstooth & Soda and Tweed Bakerstreet & Ginger — shipped in March 2020 and April 2020, respectively.

A year earlier, the Company updated its medical packaging to comply with the Cannabis Laws, resulting in smaller sized item formats.

” We understand our medical clients have been waiting for this chance to purchase a higher volume of cannabis without excess product packaging,” stated HEXO CEO and co-founder Sebastien St-Louis “Our Tsunami flower benefits from boosted humidity controls for maximum freshness and to promote perfect bud density.”

Cronos Group Inc. ( NASDAQ: CRON) (TSX: CRON.TO) recently launched its 2020 very first quarter service outcomes. The Israeli medical market is a growing channel, and we look forward to serving this market in 2020 and beyond,” said Mike Gorenstein, CEO of Cronos Group.

” Despite the difficulties and uncertainty postured by the COVID-19 pandemic, we stay agile and focused as a service. Our brand portfolio continues to introduce innovative products to consumers as we adapt to an online-first circulation model in both the U.S. and Canada We continue to reach our stakeholders and customers through creative digital marketing. And our item development and R&D jobs continue to progress. Our company believe the objective of our Business, to enhance lives through cannabinoid development, resonates specifically well during these times. We stay well-positioned and devoted to producing sustainable, long-lasting value for shareholders and are confident 2020 will be an effective building year for Cronos Group.”

cbdMD, Inc. ( NYSE: YCBD) recently reported its second financial 2020 quarter ended March 31, 2020 results. “We are delighted to report strong 2nd quarter outcomes, in addition to provide a mid-quarter update on operations. We reported $ 9.4 million in quarterly net sales, a 67%boost over the exact same quarter last year. Our gross revenue margin remains strong at 67%year-to-date and 70.9%for the quarter. Our general direct to consumer e-commerce sales for the March fiscal quarter were $ 6.8 million or 72%of our overall net sales, an increase of $ 2.5 million or 58%from the prior year’s quarter. Our B2B traditional sales were $ 2.6 million or 28%of our total net sales, a boost of $ 1.2 million or 85%from the previous year’s quarter. Direct to customer e-commerce sales for the six months ending March were $136 million or 70%of our total net sales, an increase of $ 8.9 million or 189%from the previous year period. Our B2B traditional sales were $ 5.9 million or 30%of overall net sales, a boost of $ 4.5 million or 321%from the prior year duration. Our operating expenses for the March quarter were $122 million, of which approximately $665,000 was non-cash expenditures, resulting in a money usage of $ 4.2 million for the quarter. Year to date our business expenses were $248 million, of which roughly $ 1.5 million was non-cash expenditures, resulting in a cash usage of roughly $ 9.1 million for the 6 months ending March 31, 2020,” said Martin Sumichrast, Chairman and co-CEO of the Company.

DISCLAIMER: FN Media Group LLC (FNM), which owns and operates and, is a 3rd celebration publisher and news dissemination service supplier, which shares electronic details through numerous online media channels. For present services carried out FNM has been compensated forty 6 hundred dollars for news coverage of the present press releases released by Pressure BioSciences, Inc. by the Business.

This release consists of “positive declarations” within the meaning of Section 27 A of the Securities Act of 1933, as changed, and Section 21 E the Securities Exchange Act of 1934, as amended and such positive declarations are made pursuant to the safe harbor arrangements of the Private Securities Litigation Reform Act of1995 You are cautioned that such declarations are subject to a wide variety of threats and uncertainties that could trigger future circumstances, occasions, or results to differ materially from those predicted in the positive statements, consisting of the risks that real outcomes may differ materially from those projected in the forward-looking declarations as an outcome of different aspects, and other threats recognized in a business’s yearly report on Kind 10- K or 10- KSB and other filings made by such business with the Securities and Exchange Commission.

Contact Info:
Media Contact email: [email protected]


CBD Oil, 9 Enchanting Examples Of Cannabinoid
Find out more